Skip to content

Luminal A Breast Carcinoma C3642345

Published: July 22, 2026Updated: August 20, 2026

Luminal A breast cancer is a subtype of breast cancer that typically grows slowly and has a good prognosis. These tumors usually respond well to hormone therapy and generally have lower rates of recurrence compared to other types. Treatment often includes hormone-blocking medications, chemotherapy, and targeted therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

Breast lump

(breast)

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Nipple discharge

(breast)

Skin changes

(integumentary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Endocrine therapy

Hormone-blocking medications to suppress estrogen-driven tumor growth. Typically continued for 5-10 years post-surgery to reduce recurrence risk.

medication
3

Surgical tumor resection

Breast-conserving surgery or mastectomy depending on tumor characteristics and patient preference. Often combined with sentinel lymph node evaluation for staging.

surgical

Additional treatment options

Radiation therapy

Targeted radiation to eliminate residual cancer cells following lumpectomy or as part of conservative management. Standard course typically spans several weeks.

procedure

Lifestyle modification program

Structured program including weight management, regular exercise, and alcohol reduction. These modifications may improve outcomes and reduce recurrence risk.

lifestyle

Surveillance and follow-up imaging

Long-term monitoring with regular imaging and tumor marker assessment. Includes mammography, bone density scans, and cardiac monitoring as indicated.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Luminal A Breast Carcinoma C3642345?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Luminal A Breast Carcinoma C3642345. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy